genOway Société anonyme

€1.98As of Sun 8 Nov 2026, 12:00 UTC
EPA:ALGENHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR 0.82%
Div yield —
ROE (10.35%)
Biotechnology
Beta (5Y) 0.44
PE TTM —
TSR TTM (27.92%)
Mkt cap €18.21M
ROIC (4.10%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€2.28
15.59%
(41.44%)
Hold 2|5|2|12|10
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.03
0.03
0.03
0.04
19.95%
20.69%
9.56%
4.54%
Revenue€M
1.188
1.201
1.217
1.226
7.64%
5.97%
2.64%
2.12%
Peers (US$20.45M)
Cap (US$)
PE
23.06M
—
16.67M
—
Capital
TTM
5Y
10Y
Leveragex
0.422
0.236
0.236
EBIT/Intx
1.085
1.475
1.199
Own earn%
42.65
49.89
53.42
Sh yield%
54.30
60.50
58.31
Owners
Insiders/Inst%
11.17
30.54
Short interest%
3.85
SBC / revenue%
4.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
20–28
$1 testx
—
Incr. ROIC%
15